Zhiling Yan - Blood Diseases Institute, Xuzhou Medical University

基本信息

浏览量：22

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 154 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Anti-GPRC5D CAR T-cell Therapy As a Salvage Treatment in Patients with Progressive Multiple Myeloma after Anti-Bcma CAR T-cell Therapy: a Single-Centre, Single-Arm, Phase 2 Trial

Jieyun Xia, Qian Sun,Dian Zhou,Hujun Li,Ying Wang,Yuekun Qi,Jiang Cao,Zhiling Yan,Depeng Li,Hai Cheng,Wei Sang,Feng Zhu,Haiying Sun,Wei Chen,Kunming Qi,Dongmei Yan,Tingting Qiu, Tingyu Hu,Weiying Gu,Jun Qian,Fan Xia,Na Qi, Congqian Jin,Yang Liu,Xue Wang,Yanlei Zhang, Shuixiu Peng,Zhenyu Li,Alex H Chang,Kailin Xu

The Lancet Haematologyno. 5 (2025): e365-e375

引用0浏览0WOS引用

The Impact of Antibiotic Use on Outcomes of Relapsed/refractory Multiple Myeloma Patients Treated with CAR-T Therapy

Lingling Yin, Bin Lv, Jiao Ge,Yuekun Qi,Jieyun Xia,Sha Ma,Ying Wang,Yang Liu,Dian Zhou,Jiang Cao,Zhiling Yan,Kunming Qi,Wei Sang,Depeng Li,Hai Cheng,Wei Chen,Kailin Xu,Weiying Gu,Zhenyu Li,Feng Zhu

Frontiers in immunology (2025): 1566016-1566016

引用0浏览0WOS引用

CAR T-Cell Therapy in Chronic Myeloid Leukemia Patients with Lymphoid Blast Crisis: A Multicenter Clinical Analysis

Yujie Liu,Yuqing Tu,Zhiling Yan, Jinyan Xiao, Biqi Zhou, Tianhui Liu, Lijuan Qi,Depei Wu,Yongxian Hu,Yang Cao,Yang Xu

Cancer Letters (2025): 217688

引用0浏览0WOS引用

Genetic and Epigenetic Mechanisms of GPRC5D Loss after Anti-Gprc5d CAR T-cell Therapy in Multiple Myeloma

Sha Ma,Jieyun Xia, Miao Zhang, Wenyu Li, Meng Xiao, Yuqian Sha, Wenya Wang, Jianteng Zhou,Ying Wang,Kunming Qi,Chunling Fu,Zengtian Sun,Dian Zhou, Qian Sun,Tingting Qiu,Zhiling Yan,Feng Zhu,Wei Chen,Hai Cheng,Wei Sang,Jiang Cao,Depeng Li, Zhenyu Zhen Li,Mariateresa Fulciniti, Yao,Kailin Xu,Mingshan Niu

Blood（2025）

引用0浏览0WOS引用

Lymphocyte/monocyte to Lactate Dehydrogenase Ratio Prior to Lymphodepletion Impact the Outcomes of Patients with Diffused Large B Cell Lymphoma Undergoing CAR-T Cell Therapy

Na Li, Na An,Sha Ma,Jiang Cao,Feng Zhu,Kunming Qi,Zhiling Yan,Hai Cheng,Wei Sang,Wei Chen,Depeng Li,Zhenyu Li,Kailin Xu,Ying Wang

Cancer Immunology, Immunotherapyno. 5 (2025): 1-9

引用0浏览0WOS引用

Low Intensity Daratumumab to Treat Rersistent/Recurrent Minimal Residual Disease in Multiple Myeloma

Lingzhi Yan,Xiaolan Shi,Jing Wang,Song Jin,Ying Yao, Panfeng Wang,Jingjing Shang,Yingying Zhai,Shuang Yan, Yun Xu, Jiajia Meng,Weiqin Yao, Xiao Ma,Chengcheng Fu,Depei Wu

Bloodno. Supplement 1 (2024): 4750-4750

引用0浏览0引用

Long-term Survival with Donor CD19 CAR-T Cell Treatment for Relapsed Patients after Allogeneic Hematopietic Stem Cell Transplantation

Cheng Zhang,Xiaoqi Wang,Hai Yi,Yi Wang,Zhiling Yan,Jian Zhou,Ting Yang,Aibin Liang, Zhen Wang,Yingying Ma,Qin Wen,Lei Gao,Li Gao,Peiyan Kong,Xu Tan,Erlie Jiang,Xi Zhang

Journal of Hematology & Oncologyno. 1 (2024): 1-4

引用0浏览0WOS引用

5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma

Xiaolan Shi,Chengcheng Fu,Lingzhi Yan,Yingying Zhai, Zhi Yan,Jingjing Shang,Song Jin,Xingyue Wu,Hongying You,Shuang Yan,Weiqin Yao,Liqing Kang,Lei Yu,Depei Wu

Bloodno. Supplement 1 (2024): 4766-4766

引用0浏览0引用

Clinical Outcomes and Microenvironment Profiling in Relapsed/refractory Multiple Myeloma Patients with Extramedullary Disease Receiving Anti-Bcma CAR T-cell-based Therapy

AMERICAN JOURNAL OF HEMATOLOGYno. 12 (2024): 2286-2295

引用0浏览0WOS引用

Real World Analysis of the Efficacy, Prognosis and Safety of Daratumumab, Carfilzomib, and Dexamethasone (DKD) in Relapsed or Refractory Multiple Myeloma Patients

Chengcheng Fu,Hongying You,Song Jin, Panfeng Wang,Lingzhi Yan,Liying Zhang, Tingting Lu, Xiao Gao, Lei Jiang, Hongchun Qiu,Jingjing Shang,Yingying Zhai,Weiqin Yao,Shuang Yan, Zhi Yan,Depei Wu

BLOOD (2024): 6992-6993

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn